Midatech Pharma PLC-ADR (NASDAQ:MTP)’s share price traded down 9% during trading on Friday . The company traded as low as $0.35 and last traded at $0.38. 572,090 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 2,908,298 shares. The stock had previously closed at $0.42.
Separately, ValuEngine cut shares of Midatech Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd.
The company has a market capitalization of $13.29 million, a P/E ratio of -0.52 and a beta of 3.53.
TRADEMARK VIOLATION WARNING: This news story was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/4224669/midatech-pharma-mtp-stock-price-down-9.html.
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer.
Featured Article: What is a Backdoor Roth IRA?
Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.